Upload
easter-ryan
View
217
Download
2
Embed Size (px)
Citation preview
HLA Genotyping Data Generated by 454 Sequencing
Cherie Holcomb, Ph.D.Roche Molecular Systems
picture placeholder
NGS Data Consortium October 8, 2012
Medium, High, and Very High Resolution HLA Genotyping SystemsTargeted Amplicon sequencing
–Primers target up to 9 loci (format as fusion primers or “4 primer system” w/use of Fluidigm Access Array™)
• NOTE: After amplification of gDNA, amplicons contain all adapters & MIDs etc. for NGS sequencing
–Workflow: Amplicons processed either individually or pooled (fusion primers) or pooled (“4 primer system”)
–454 Life Sciences GS FLX or GS Junior for NGS
–Conexio Assign ATF 454 software (commercially available will perform MR and HR; for VHR limited early access to Conexio Assign MPS v1.0)
Amplicon Sequencing using 454 GS FLX*
*GS Junior can also be used, ~8x fewer samples per run∆Abstract #1025-LB ǂAbstract #ORO1-02
NOTE: All current products are for Research Use Only
ResolutionPossible/Future
Applications# Primer
Pairs LociMethod of Amplicon
Generation# Samples per GS FLX
run achieved Advantages Disadvantages454 fusion primer plates
(simplification of workflow by pooling amplicons possible)
88 (limited by MID/PTP region combination if use commercial
product) Commercially available
Storing primer plates at 4oC; Limited to 11 MIDs-limits # of samples per run
Fluidigm Access Array™∆ 192
More MIDs→higher throughput; Less
sample consumption & PCR reagent consumption
Need to purchase Fluidigm instrumentation &
disposables
454 fusion primer plates (workflow as above)
88 (limitation as above)
Fluidigm Access Array™∆ 96
454 fusion primer plates
(workflow as above)ǂ
MR & HR plates commercially available, (VHR primers could be
added on by lab)
Storing plates at 4oC; need to store VHR primers in diff format (liquid) unless made
commercially available
Fluidigm Access Array™ǂLess sample
consumption & PCR reagent consumption
as above
Unrelated bone marrow donor
registry screening
"Medium" (MR)
"High" (HR) As above As above
A, B, C, DQB1, DRB1 (also get DRB3/4/5)
& DQA1, DPB1
8
14
40-48 (conservative est)"Very High"
(VHR)Clinical
& DPA1
22
Research
Primer Set ComparisonGS GType MR, HR with added VHR* amplicons
MR Primers HR Primers VHRCLASS I
• HLA-A: 2, 3 2, 3, 4 1, 2, 3, 4-5
• HLA-B: 2, 3 2, 3, 4 1, 2, 3, 4, 5
• HLA-C: 2, 3 2, 3, 4 1, 2, 3, 4, 5, 6-7
CLASS II
• DPA1 exon: N/A N/A 2
• DPB1 exon: N/A 2 2
• DQA1 exon: N/A 2 2
• DQB1 exons: 2 2, 3 2, 3
• DRB1 exon: 2 2 2, 3
• DRB 3, 4, 5 exon: 2 2 2, 3
*Numbers shown are exons, “-” indicates intron
454 GS GType HLA Primer Sets
Primer Plate Layout for Very High Resolution Sequencing 9 loci, 22 primer pairs, 11 MIDs, 10 samples per set (3 plates)MR Plate
1 2 3 4 5 6 7 8 9 10 11 12A A2 A2 A2 A2 A2 A2 A2 A2 A2 A2 Neg (-) B A3 A3 A3 A3 A3 A3 A3 A3 A3 A3 Neg (-) C B2 B2 B2 B2 B2 B2 B2 B2 B2 B2 Neg (-) D B3 B3 B3 B3 B3 B3 B3 B3 B3 B3 Neg (-) E C2 C2 C2 C2 C2 C2 C2 C2 C2 C2 Neg (-) F C3 C3 C3 C3 C3 C3 C3 C3 C3 C3 Neg (-) G DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 DQB1 E2 Neg (-) H DRB E2 DRB1 E2 DRB1 E2 DRB1 E2 DRB1 E2 DRB1 E2 DRB1 E2 DRB1 E2 DRB1 E2 DRB1 E2 Neg (-)
HR PlateA A4-5 A4-5 A4-5 A4-5 A4-5 A4-5 A4-5 A4-5 A4-5 A4-5 Neg (-) B B4 B4 B4 B4 B4 B4 B4 B4 B4 B4 Neg (-) C C4 C4 C4 C4 C4 C4 C4 C4 C4 C4 Neg (-) D DPB1 DPB1 DPB1 DPB1 DPB1 DPB1 DPB1 DPB1 DPB1 DPB1 Neg (-) E DQA1 DQA1 DQA1 DQA1 DQA1 DQA1 DQA1 DQA1 DQA1 DQA1 Neg (-) F DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 DQB1 E3 Neg (-) GH
VHR PlateA A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 Neg (-) B B1 B1 B1 B1 B1 B1 B1 B1 B1 B1 Neg (-) C C1 C1 C1 C1 C1 C1 C1 C1 C1 C1 Neg (-) D B5 B5 B5 B5 B5 B5 B5 B5 B5 B5 Neg (-) E C5 C5 C5 C5 C5 C5 C5 C5 C5 C5 Neg (-) F C6-7 C6-7 C6-7 C6-7 C6-7 C6-7 C6-7 C6-7 C6-7 C6-7 Neg (-) G DPA1 DPA1 DPA1 DPA1 DPA1 DPA1 DPA1 DPA1 DPA1 DPA1 Neg (-) H DRB E3 DRB E3 DRB E3 DRB E3 DRB E3 DRB E3 DRB E3 DRB E3 DRB E3 DRB E3 Neg (-)
454 Amplicon Sequencing File Generation
454 Pyrosequencing
Image Acquisition
Image Processing Image
Processed CWF
Signal Processing
PNG
Examine seq
Signal Processed CWF
Signal Processing
Signal Processing SFFFNA
(FASTA)
Consolidation (454 AVA software)
Consolidated FNA
(FASTA)
Genotype Report Genotyping
Sequence Export +
(Conexio Assign)
Conexio Assign ATF 454 InterfaceGenotypes automatically assigned , sequences visible
Conexio Assign ATF 454 InterfaceGenotype Report allele name format and output format can be chosen
Conexio Assign MPS v1.0 Genotyping ReportAll fields, MS Excel format
454 GS GType HLA +VHR primers—only part of report shown; assay includes DQA1, DQB1, DRB1 and DRB3/4/5
A CWD filter OR “highlighting” of CWD alleles in report (preferred) has been requested
GS GType HLA HR primers, Conexio Assign MPSv1.0References for gDNA; Noncoding sequence can be consideredHLA-A genotype: Ambiguity String includes A*03:01:01:02N
NC seq not activated
Null
GS GType HLA VHR primers, Conexio MPSv1.0Noncoding sequence is activated, ambiguity string greatly reducedHLA-A genotype: A*02:01:01:01/02L, A*03:01:01:01
NC seq activated; Null resolved
CHALLENGE: How could/should these sequences be reported?
Reporting of Sequence Information
Currently
• Can report out (combined) consensus exon sequence that has given rise to list of possible genotypes for a given sample/locus. Can do this easily for all samples. (Q: If community decides sequence is necessary for publications, is this sufficient?)
– Cannot report component (consensus) sequences (with exons matched) to give individual allele(s)
– Doesn’t include intronic sequence (but can report consensus of each intron individually—too laborious to be practical)
– FASTA format in notepad (Q: Sufficient for publication?)
Reporting of Sequence Information
Preferred
• Option to report component sequences (with exons and introns matched) to give allele calls—imp for reporting new alleles
• For (combined or individual alleles) consensus sequence
–Option to report Coding only OR Coding plus Noncoding
–Format options including XML (accepted by IMGT)—imp for reporting new allelesWorks in Progress
GS GType HLA VHR primers, Conexio MPSv1.0New allele can be identifiedGenotype has 1 mismatch w/IMGT database; can determine in which allele
GS GType HLA VHR primers, Conexio MPSv1.0DRB1*12 allele is a perfect match with IMGT database
GS GType HLA VHR primers, Conexio MPSv1.0New allele is identifiableDRB1*07:01 allele has 1 mismatch w/IMGT database (A at b259 instead of G)
Proposed acceptance criteria: Sequenced multiple times (2 different runs); Minimum read depth of 25 for each direction, each allele for (all) amplicons of prospective new allele; Mutation(s) defining new allele observed in both F and R direction
Confirmed by Sanger sequencing
Reporting Sequences for New AlleleUsing info from Res Layers, manually harvest sequences and assemble 1 allele
“Copy Sequence” Output Simple Text file: Copy into Word Pad, Excel, Bioedit
Assume XML is most appropriate for submission to IMGT database
Not in FASTA or XML format (currently no way to convert to latter)
In discussion with Conexio
Gaps in IMGT database create ambiguity in typingGaps indicated by “orange bar” in user interface but not in Genotyping Report
etc.
Issue: Would be good if alleles lacking sequence were flagged in Genotyping Report
In discussion with Conexio
Additional info & Summary
• Using HR or VHR 454 sequencing HLA genotyping system including Conexio Assign ATF 454 or MPS v1.0 software, respectively:
– Ambiguity string lengths are reduced to a practically reportable size– Genotype/ allele ambiguity strings (in various formats using
combinations of delineation in columns, “+”, “or”, “,”) can be reported in Excel, text and XML(??) format at 1, 2, or all field level.
– NMDP codes supported– Most recent IMGT nomenclature and references supported (updated
with periodicity, 6 months); version of references used is reported– Export of consensus sequence used to make genotype calls for all
loci/all samples is easily accomplished in FASTA format—currently doesn’t include NC sequence.
– New alleles readily identifiable, however, reporting of amplicon sequences currently only possible by manual “harvesting” into text file.
Acknowledgements
• Roche Molecular Systems– Henry Erlich
• Conexio Genomics– Damian Goodridge
We Innovate Healthcare
22
23
Back-up slides
Ambiguity C*03:03/ 03:20NGS GType HLA HR primers
Ambiguity Resolution C*03:03/ 03:20NVHR primers